Dr. Benjamin Robert Mchone, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5700 W Genesee St Ste 124, Camillus, NY 13031 Phone: 315-478-4185 Fax: 315-478-0840 |
News Archive
Children of farm workers are three times as likely as all other children and almost twice as likely as other poor children to be uninsured, according to a report in the December issue of Archives of Pediatrics & Adolescent Medicine.
Here's a hypothetical scenario: You're the president. You've just botched the roll out of what should have been your signature accomplishment, a major reform of the health insurance system. The public's hopping mad because you said anyone who liked his insurance plan would be able to keep it, but that wasn't true. So what do you do now? What the actual president did was suggest we all discuss health insurance with their families this holiday season (Andrew Rosenthal, 11/20).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.
The Bellvitge Biomedical Research Institute has licensed to the company Oxford Immunotec, a technology to measure the secretion of anti-HLA antibodies from memory B cells to improve the efficiency of kidney transplants and prevent rejection of graft.
› Verified 6 days ago